Egenskap
Fainting spell
Klinisk navn: Syncope
A transient loss of consciousness (i.e., characterized by a rapid onset, a short duration, and a spontaneous and complete recovery) due to cerebral hypoperfusion.
Sammendrag
ReferansegenomGRCh38hg38
Posisjoner på gen- og variantsidene følger dette valget i denne nettleseren.
Read the genes linked to Fainting spell, and the rest of your genome, with one test.
Fra 449 $Gratis frakt · Resultater på 6–8 uker
Få mitt Genome Test139 gener knyttet til Fainting spell
Endringer i disse genene forårsaker sjeldne tilstander der Fainting spell forekommer. De fleste med denne egenskapen har ingen av disse tilstandene, og et gen på denne listen sier ingenting om noens eget genom.
| Gen | Hvor ofte den forekommer | Tilstander |
|---|---|---|
| AKAP9A-kinase anchoring protein 9 | Alltid | I 2 tilstander |
| ARHGEF15Rho guanine nucleotide exchange factor 15 | Alltid | I 1 tilstand |
| CALM1calmodulin 1 | Alltid | I 1 tilstand |
| CASQ2calsequestrin 2 | Alltid | I 2 tilstander |
| CTSAcathepsin A | Alltid | I 1 tilstand |
| GYS1glycogen synthase 1 | Alltid | I 2 tilstander |
| HIVEP2HIVEP zinc finger 2 | Alltid | I 1 tilstand |
| KCNE1potassium voltage-gated channel subfamily E regulatory subunit 1 | Alltid | I 4 tilstander |
| KCNQ1potassium voltage-gated channel subfamily Q member 1 | Alltid | I 7 tilstander |
| LMNAlamin A/C | Alltid | I 2 tilstander |
| NOTCH3notch receptor 3 | Alltid | I 1 tilstand |
| POPDC1popeye domain cAMP effector 1 | Alltid | I 1 tilstand |
| SNTA1syntrophin alpha 1 | Alltid | I 1 tilstand |
| CALM2calmodulin 2 | Svært ofte (80–99 %) | I 1 tilstand |
| HCN4hyperpolarization activated cyclic nucleotide gated potassium channel 4 | Svært ofte (80–99 %) | I 2 tilstander |
| KCNJ5potassium inwardly rectifying channel subfamily J member 5 | Svært ofte (80–99 %) | I 3 tilstander |
| LAMP2lysosome associated membrane protein 2 | Svært ofte (80–99 %) | I 2 tilstander |
| NIT1nitrilase 1 | Svært ofte (80–99 %) | I 1 tilstand |
| RYR2ryanodine receptor 2 | Svært ofte (80–99 %) | I 1 tilstand |
| TRDNtriadin | Svært ofte (80–99 %) | I 2 tilstander |
| ABCC9ATP binding cassette subfamily C member 9 | Ofte (30–79 %) | I 2 tilstander |
| ALG10BALG10 alpha-1,2-glucosyltransferase B | Ofte (30–79 %) | I 1 tilstand |
| CACNA1Ccalcium voltage-gated channel subunit alpha1 C | Ofte (30–79 %) | I 3 tilstander |
| CACNA1Dcalcium voltage-gated channel subunit alpha1 D | Ofte (30–79 %) | I 1 tilstand |
| CACNA2D1calcium voltage-gated channel auxiliary subunit alpha2delta 1 | Ofte (30–79 %) | I 2 tilstander |
| CACNB2calcium voltage-gated channel auxiliary subunit beta 2 | Ofte (30–79 %) | I 2 tilstander |
| CAV3caveolin 3 | Ofte (30–79 %) | I 1 tilstand |
| DBHdopamine beta-hydroxylase | Ofte (30–79 %) | I 1 tilstand |
| DLSTdihydrolipoamide S-succinyltransferase | Ofte (30–79 %) | I 1 tilstand |
| DNMT3ADNA methyltransferase 3 alpha | Ofte (30–79 %) | I 1 tilstand |
| DSC2desmocollin 2 | Ofte (30–79 %) | I 1 tilstand |
| ELNelastin | Ofte (30–79 %) | I 1 tilstand |
| EPAS1endothelial PAS domain protein 1 | Ofte (30–79 %) | I 1 tilstand |
| FHfumarate hydratase | Ofte (30–79 %) | I 1 tilstand |
| GATA4GATA binding protein 4 | Ofte (30–79 %) | I 2 tilstander |
| GATA5GATA binding protein 5 | Ofte (30–79 %) | I 1 tilstand |
| GATA6GATA binding protein 6 | Ofte (30–79 %) | I 2 tilstander |
| GJA5gap junction protein alpha 5 | Ofte (30–79 %) | I 1 tilstand |
| GPD1Lglycerol-3-phosphate dehydrogenase 1 like | Ofte (30–79 %) | I 2 tilstander |
| JUPjunction plakoglobin | Ofte (30–79 %) | I 2 tilstander |
Vis 99 gener til
| Gen | Hvor ofte den forekommer | Tilstander |
|---|---|---|
| KCNA5potassium voltage-gated channel subfamily A member 5 | Ofte (30–79 %) | I 1 tilstand |
| KCND3potassium voltage-gated channel subfamily D member 3 | Ofte (30–79 %) | I 1 tilstand |
| KCNE2potassium voltage-gated channel subfamily E regulatory subunit 2 | Ofte (30–79 %) | I 2 tilstander |
| KCNE3potassium voltage-gated channel subfamily E regulatory subunit 3 | Ofte (30–79 %) | I 1 tilstand |
| KCNE5potassium voltage-gated channel subfamily E regulatory subunit 5 | Ofte (30–79 %) | I 1 tilstand |
| KCNH2potassium voltage-gated channel subfamily H member 2 | Ofte (30–79 %) | I 3 tilstander |
| KCNJ2potassium inwardly rectifying channel subfamily J member 2 | Ofte (30–79 %) | I 4 tilstander |
| KCNJ3potassium inwardly rectifying channel subfamily J member 3 | Ofte (30–79 %) | I 1 tilstand |
| KCNJ8potassium inwardly rectifying channel subfamily J member 8 | Ofte (30–79 %) | I 1 tilstand |
| KIF1Bkinesin family member 1B | Ofte (30–79 %) | I 1 tilstand |
| MAXMYC associated transcriptional regulator X | Ofte (30–79 %) | I 1 tilstand |
| MDH2malate dehydrogenase 2 | Ofte (30–79 %) | I 1 tilstand |
| MYL4myosin light chain 4 | Ofte (30–79 %) | I 1 tilstand |
| NF1neurofibromin 1 | Ofte (30–79 %) | I 1 tilstand |
| NKX2-5NK2 homeobox 5 | Ofte (30–79 %) | I 3 tilstander |
| NKX2-6NK2 homeobox 6 | Ofte (30–79 %) | I 1 tilstand |
| NPPAnatriuretic peptide A | Ofte (30–79 %) | I 2 tilstander |
| NUP155nucleoporin 155 | Ofte (30–79 %) | I 1 tilstand |
| PITX2paired like homeodomain 2 | Ofte (30–79 %) | I 1 tilstand |
| PKP2plakophilin 2 | Ofte (30–79 %) | I 2 tilstander |
| PRKAG2protein kinase AMP-activated non-catalytic subunit gamma 2 | Ofte (30–79 %) | I 2 tilstander |
| PSEN1presenilin 1 | Ofte (30–79 %) | I 1 tilstand |
| RANGRFRAN guanine nucleotide release factor | Ofte (30–79 %) | I 1 tilstand |
| RETret proto-oncogene | Ofte (30–79 %) | I 2 tilstander |
| SCN10Asodium voltage-gated channel alpha subunit 10 | Ofte (30–79 %) | I 1 tilstand |
| SCN1Bsodium voltage-gated channel beta subunit 1 | Ofte (30–79 %) | I 3 tilstander |
| SCN2Bsodium voltage-gated channel beta subunit 2 | Ofte (30–79 %) | I 2 tilstander |
| SCN3Bsodium voltage-gated channel beta subunit 3 | Ofte (30–79 %) | I 2 tilstander |
| SCN4Bsodium voltage-gated channel beta subunit 4 | Ofte (30–79 %) | I 1 tilstand |
| SCN5Asodium voltage-gated channel alpha subunit 5 | Ofte (30–79 %) | I 9 tilstander |
| SCNN1Asodium channel epithelial 1 subunit alpha | Ofte (30–79 %) | I 1 tilstand |
| SDHAsuccinate dehydrogenase complex flavoprotein subunit A | Ofte (30–79 %) | I 1 tilstand |
| SDHAF2succinate dehydrogenase complex assembly factor 2 | Ofte (30–79 %) | I 1 tilstand |
| SDHBsuccinate dehydrogenase complex iron sulfur subunit B | Ofte (30–79 %) | I 2 tilstander |
| SDHCsuccinate dehydrogenase complex subunit C | Ofte (30–79 %) | I 1 tilstand |
| SDHDsuccinate dehydrogenase complex subunit D | Ofte (30–79 %) | I 2 tilstander |
| SEMA3Asemaphorin 3A | Ofte (30–79 %) | I 1 tilstand |
| SLC25A11solute carrier family 25 member 11 | Ofte (30–79 %) | I 1 tilstand |
| SLMAPsarcolemma associated protein | Ofte (30–79 %) | I 1 tilstand |
| TECRLtrans-2,3-enoyl-CoA reductase like | Ofte (30–79 %) | I 1 tilstand |
| TMEM127transmembrane protein 127 | Ofte (30–79 %) | I 1 tilstand |
| TRPM4transient receptor potential cation channel subfamily M member 4 | Ofte (30–79 %) | I 3 tilstander |
| TTNtitin | Ofte (30–79 %) | I 1 tilstand |
| VHLvon Hippel-Lindau tumor suppressor | Ofte (30–79 %) | I 2 tilstander |
| ABCC8ATP binding cassette subfamily C member 8 | Noen ganger (5–29 %) | I 1 tilstand |
| ACTC1actin alpha cardiac muscle 1 | Noen ganger (5–29 %) | I 2 tilstander |
| ANK2ankyrin 2 | Noen ganger (5–29 %) | I 1 tilstand |
| ASXL1ASXL transcriptional regulator 1 | Noen ganger (5–29 %) | I 1 tilstand |
| CTSHcathepsin H | Noen ganger (5–29 %) | I 1 tilstand |
| DSPdesmoplakin | Noen ganger (5–29 %) | I 1 tilstand |
| GNB2G protein subunit beta 2 | Noen ganger (5–29 %) | I 1 tilstand |
| HCRThypocretin neuropeptide precursor | Noen ganger (5–29 %) | I 1 tilstand |
| HLA-DQB1major histocompatibility complex, class II, DQ beta 1 | Noen ganger (5–29 %) | I 1 tilstand |
| HLA-DRB1major histocompatibility complex, class II, DR beta 1 | Noen ganger (5–29 %) | I 1 tilstand |
| HNF1AHNF1 homeobox A | Noen ganger (5–29 %) | I 1 tilstand |
| JAK2Janus kinase 2 | Noen ganger (5–29 %) | I 1 tilstand |
| KCNJ11potassium inwardly rectifying channel subfamily J member 11 | Noen ganger (5–29 %) | I 1 tilstand |
| KITKIT proto-oncogene, receptor tyrosine kinase | Noen ganger (5–29 %) | I 1 tilstand |
| MOGmyelin oligodendrocyte glycoprotein | Noen ganger (5–29 %) | I 1 tilstand |
| MPLMPL proto-oncogene, thrombopoietin receptor | Noen ganger (5–29 %) | I 1 tilstand |
| MYBPC3myosin binding protein C3 | Noen ganger (5–29 %) | I 2 tilstander |
| MYOZ2myozenin 2 | Noen ganger (5–29 %) | I 1 tilstand |
| NOTCH2NLCnotch 2 N-terminal like C | Noen ganger (5–29 %) | I 1 tilstand |
| NTRK1neurotrophic receptor tyrosine kinase 1 | Noen ganger (5–29 %) | I 1 tilstand |
| P2RY11purinergic receptor P2Y11 | Noen ganger (5–29 %) | I 1 tilstand |
| PSEN2presenilin 2 | Noen ganger (5–29 %) | I 1 tilstand |
| RNF125ring finger protein 125 | Noen ganger (5–29 %) | I 1 tilstand |
| SLC4A3solute carrier family 4 member 3 | Noen ganger (5–29 %) | I 2 tilstander |
| SLC6A5solute carrier family 6 member 5 | Noen ganger (5–29 %) | I 1 tilstand |
| SRSF2serine and arginine rich splicing factor 2 | Noen ganger (5–29 %) | I 1 tilstand |
| TET2tet methylcytosine dioxygenase 2 | Noen ganger (5–29 %) | I 1 tilstand |
| THPOthrombopoietin | Noen ganger (5–29 %) | I 1 tilstand |
| TLL1tolloid like 1 | Noen ganger (5–29 %) | I 2 tilstander |
| TNFSF4TNF superfamily member 4 | Noen ganger (5–29 %) | I 1 tilstand |
| TNNC1troponin C1, slow skeletal and cardiac type | Noen ganger (5–29 %) | I 1 tilstand |
| TRIM63tripartite motif containing 63 | Noen ganger (5–29 %) | I 1 tilstand |
| UCP2uncoupling protein 2 | Noen ganger (5–29 %) | I 1 tilstand |
| ZNF365zinc finger protein 365 | Noen ganger (5–29 %) | I 1 tilstand |
| AKT1AKT serine/threonine kinase 1 | Sjelden (1–4%) | I 1 tilstand |
| BAP1BRCA1 associated deubiquitinase 1 | Sjelden (1–4%) | I 1 tilstand |
| CITED2Cbp/p300 interacting transactivator with ED-rich tail 2 | Sjelden (1–4%) | I 1 tilstand |
| CLCNKBchloride voltage-gated channel Kb | Sjelden (1–4%) | I 1 tilstand |
| FLNCfilamin C | Sjelden (1–4%) | I 1 tilstand |
| KIF20Akinesin family member 20A | Sjelden (1–4%) | I 1 tilstand |
| MYH6myosin heavy chain 6 | Sjelden (1–4%) | I 1 tilstand |
| MYPNmyopalladin | Sjelden (1–4%) | I 1 tilstand |
| NF2NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor | Sjelden (1–4%) | I 1 tilstand |
| PDGFBplatelet derived growth factor subunit B | Sjelden (1–4%) | I 1 tilstand |
| PIK3CAphosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | Sjelden (1–4%) | I 1 tilstand |
| SLC12A3solute carrier family 12 member 3 | Sjelden (1–4%) | I 1 tilstand |
| SMARCB1SWI/SNF related BAF chromatin remodeling complex subunit B1 | Sjelden (1–4%) | I 1 tilstand |
| SMARCE1SWI/SNF related BAF chromatin remodeling complex subunit E1 | Sjelden (1–4%) | I 1 tilstand |
| SMOsmoothened, frizzled class receptor | Sjelden (1–4%) | I 1 tilstand |
| SUFUSUFU negative regulator of hedgehog signaling | Sjelden (1–4%) | I 1 tilstand |
| TBX20T-box transcription factor 20 | Sjelden (1–4%) | I 1 tilstand |
| TERTtelomerase reverse transcriptase | Sjelden (1–4%) | I 1 tilstand |
| TNNI3troponin I3, cardiac type | Sjelden (1–4%) | I 1 tilstand |
| TNNT2troponin T2, cardiac type | Sjelden (1–4%) | I 1 tilstand |
| TRAF7TNF receptor associated factor 7 | Sjelden (1–4%) | I 1 tilstand |
Hvor ofte dette forekommer hos personer med en av genets tilstander, oppgitt som den hyppigste forekomsten blant dem, slik Human Phenotype Ontology registrerer den. Disse sidene beskriver egenskaper og forskningen bak dem. De er ikke en diagnose, og om symptomer bør du spørre lege eller genetisk rådgiver.
Smalere egenskaper
Bredere egenskaper
Slik er informasjonen samlet
- Human Phenotype Ontology, versjon 2026-09-01: egenskapen, navnene på den, definisjonen og genene som er knyttet til den. Les mer på hpo.jax.org.
- Datautgave 2026.10.16-c6eea6bf.
Én test. En livstid med svar.
Fra 449 $Gratis frakt · Resultater på 6–8 uker